50
Participants
Start Date
November 20, 2024
Primary Completion Date
October 30, 2026
Study Completion Date
October 30, 2026
Dexmedetomidine
Dexmedetomidine has become more popular as a caudal adjuvant in children; it is a highly selective α2 agonist with sedative and analgesic properties. Dexmedetomidine possesses anxiolytic, sedative, sympatholytic, and analgesic properties without respiratory depressant effects In addition; dexmedetomidine has the ability to reduce both the anesthetic and opioid analgesic requirements during the perioperative period.
Bupivacain
Bupivacaine is a potent local anesthetic with unique characteristics from the amide group of local anesthetics.
Assiut University
OTHER